The Government has launched the PLI Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs) / Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India (also known as the PLI Scheme for Bulk Drugs) to promote the establishment of new pharmaceutical industrial units. The PLI Scheme for Bulk Drugs has a budgetary outlay of ₹6,940 crore, and it aims to improve self-reliance and reduce import dependence in critical KSMs, DIs and APIs. As of December 2025, 48 greenfield projects have been approved under the scheme with committed investment of ₹4,329.95 crore, against which actual investment of ₹4,814.1 crore has been made. 38 projects have been commissioned, resulting in establishment of domestic manufacturing capacity of approximately 56,800MT per annum. Details of projects approved under PLI Scheme for Bulk Drugs, State-wise and district-wise are placed at Annexure.

The Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme has been launched by the Government with an outlay of ₹5,000 crore to transform India’s Pharma MedTech sector including Madhya Pradesh and Dadra and Nagar Haveli, from cost-based to innovation-based growth by strengthening research and to promote industry-academia linkage for research and development in priority areas in drug discovery and development and medical devices. Under this, seven Centres of Excellence (CoEs) have been set up, with total budgetary support to the tune of ₹700 crore, to create research infrastructure and promote R&D in identified areas. The CoEs have so far approved 104 research projects under the scheme and have filed two patents. The scheme also includes an outlay of ₹4,250 crore for support to industry and startups, including in collaboration with academia, for undertaking research and innovation projects in priority areas.

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana was launched by the Government of India to make quality generic medicines available at affordable prices for all citizens. Under this scheme, special outlets called Jan Aushadhi Kendras are opened across the country which provide medicines that are about 50% to 80% cheaper than branded medicines, helping reduce healthcare expenses for patients. Under the scheme, 634 JAKs in Madhya Pradesh and 41 JAKs in the Union Territory of Dadra and Nagar Haveli and Daman & Diu have been opened which aim to increase the availability of affordable medicines in Madhya Pradesh and Union Territory of Dadra and Nagar Haveli and Daman & Diu. Further, to increase availability of medicines, Pharmaceutical & Medical Devices Bureau of India (PMBI), which is the implementing agency of the PMBJP scheme, utilises an end-to-end information-technology-enabled supply chain system through which availability of medicines are monitored in these JAKs. The JAKs are incentivised to maintain the stocks of 200 high demand products under the scheme. In addition, 400 fast-moving products are monitored regularly by PMBI with periodic forecasting aided by digital tools.

Annexure

Details of approved projects under the PLI Scheme for Bulk Drugs, State-wise and district-wise:

 

This information was given by Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, in a written reply in the Lok Sabha today.

*****

PC/PM

(Release ID: 2246061) Visitor Counter : 136